Eterna Therapeutics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | 2.01 | -100% |
| P/S |
|
146.14 | 33.76 | 332.9% |
|
|
| P/BV |
|
4.45 | 4.82 | -7.69% |
|
|
| P/FCF |
|
0 | 60.98 | -100% |
|
|
| Ev/Ebitda |
|
-2.26 | -22.12 | -89.78% |
|
|
| Ev/S |
|
650.08 | 22.56 | 2781.13% |
|
|
| Ev/FCF |
|
-2.16 | 68.75 | -103.15% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-28751.47 | 4.83 | -595323.38% | -24660906.27 | -99.88% |
| ROE |
|
-970.35 | 9.61 | -10201.37% |
|
|
| ROA |
|
-44.1 | 0.3359 | -13229.17% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-31864.71 | -25.17 | 126497.39% |
|
|
| ROCE |
|
-925.84 | 15.33 | -6138.93% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.4598 | -3.67 | -87.46% | -0.2241 | 105.19% |
| Nеt Debt/Ebitda |
|
-1.75 | -3.44 | -49.03% |
|
|
| Debt/Ratio |
|
0.183 | 0.1972 | -7.2% |
|
|
| Debt/Equity |
|
0 | 1.65 | -100% |
|
|
| Debt/Net Income |
|
-0.4149 | 10.31 | -104.03% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% |
|
|
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0.1344 | 43.56 | -99.69% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
-99.68 | -56.89 | 75.22% |
| Growth impulse Ebitda 5 years |
|
-475.98 | -64.81 | 634.42% |
| Growth impulse Net Income 5 years |
|
983.4 | -58.33 | -1785.92% |
| Growth impulse FCF 5 years |
|
-885.65 | -47 | 1784.36% |
| Growth impulse EPS 5 years |
|
472.69 | -32.41 | -1558.47% |
IP Score
3.45/10
